28 News & Informationen zur Dynavax Technologies Aktie

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
    Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap …

  • The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology...
    markets.businessinsider.com

    The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…

  • Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine
    entrepreneur.com

    Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

    Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.

  • NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High
    entrepreneur.com

    NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High

    NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High

  • 60 Biggest Movers From Yesterday
    markets.businessinsider.com

    60 Biggest Movers From Yesterday

    Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…

  • NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High
    investing.com

    NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High

    Stocks Analysis by Zacks Investment Research covering: CBRE Group Inc Class A, Pfizer Inc, Chubb Ltd, Textron Inc. Read Zacks Investment Research's latest article on Investing.com

  • Valneva : Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine (Form 6-K)
    marketscreener.com

    Valneva : Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine (Form 6-K)

    Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine

    Saint-Herblain , August 23, 2021 – ValnevaSE , a specialty vaccine company focused… | August 23, 2021

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    During Friday's morning session, 137 companies made new 52-week highs.
    Areas of Significance: Johnson & Johnson (NYSE:JNJ) was the …

  • The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
    markets.businessinsider.com

    The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…

  • Former Penny Stocks To Watch After Merck’s (MRK) Latest FDA Win
    pennystocks.com

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Thursday's morning session saw 119 companies set new 52-week highs.
    Areas of Significance: Wells Fargo (NYSE:WFC) was the largest company by …

  • Hot Biotech Stocks That Deserve Your Attention In August 2021
    pennystocks.com

  • Hot Biotech Stocks That Deserve Your Attention In August 2021
    entrepreneur.com

    Hot Biotech Stocks That Deserve Your Attention In August 2021

    Is it time to add biotech stocks to your list this year?

  • Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
    pennystocks.com

  • Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q2 2021 Results – Earnings Call Transcript

    Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2021 Results Conference Call August 05, 2021 04:30 PM ET Company Participants Nicole Arndt – Senior Manager, IR Ryan Spencer – CEO Kelly…

  • Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top Estimates
    zacks.com

    Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top Estimates

    Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 150.00% and 19.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Should I Avoid Constellation Pharmaceuticals, Inc. (CNST)?
    insidermonkey.com

    Should I Avoid Constellation Pharmaceuticals, Inc. (CNST)?

    We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on…

  • Hedge Funds Are Crazy About ESSA Pharma Inc. (EPIX)
    insidermonkey.com

    Hedge Funds Are Crazy About ESSA Pharma Inc. (EPIX)

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….

  • Covid-19: The daily dose (July 7, 2021)
    thehindubusinessline.com

    Covid-19: The daily dose (July 7, 2021)

    We curate for you all the Covid-19-related developments and stories of the day worth reading

  • Dynavax, Biological E ink agreement for Corbevax
    thehindubusinessline.com

  • Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate
    prnewswire.com

    Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate

    /PRNewswire/ — Dynavax Technologies Corporation (Dynavax, Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines…

  • Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    prnewswire.com

    Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of…

  • Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
    marketscreener.com

    Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration

    NEW YORK, July 2, 2021 /PRNewswire/ — While the economy is slowly coming back to normal, concerns over the hyper-transmissible delta variant are rising. According to the CDC, the number of new…

  • Why Dynavax Stock Has Jumped 11% So Far This Week
    fool.com

    Why Dynavax Stock Has Jumped 11% So Far This Week

    The company inked a significant supply deal for its vaccine adjuvant.

  • Dynavax Technologies : Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine...
    marketscreener.com

    Dynavax Technologies : Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate

    Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 Pending conditional regulatory approvals, Clover expects to… | June 30, 2021

  • Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    markets.businessinsider.com

    Dynavax Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    EMERYVILLE, Calif., June 29, 2021 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX) today announced that, in connection with the app…

  • Why Dynavax Stock Jumped Today
    fool.com

  • Cancer Vaccines Market to reach US $10,688.8 Million By 2028 - Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Drivers,...
    benzinga.com

    Cancer Vaccines Market to reach US $10,688.8 Million By 2028 – Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Drivers, Expansion Plans and Future Outlook: Adroit Market Research

    Dallas, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) — The “Global Cancer Vaccines Market Size 2020, By Type (Preventive Cancer Vaccines, Therapeutic Cancer …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

6 ETFs die in Dynavax Technologies investieren

Dir gefallen die Informationen zu Dynavax Technologies?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Dynavax Technologies?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Dynavax Technologies?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Dynavax Technologies?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba